CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Clinical trial NCT04698187 · TERMINATED
Trial details
- NCT number
- NCT04698187
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-11
- Primary completion
- 2024-02-05
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.